Alpha Teknova (TKNO) Competitors $5.18 +0.01 (+0.19%) Closing price 07/25/2025 04:00 PM EasternExtended Trading$5.25 +0.07 (+1.35%) As of 07/25/2025 07:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock TKNO vs. NRIX, QURE, SNDX, TRVI, MENS, NAGE, XERS, NUVB, MAZE, and CRONShould you be buying Alpha Teknova stock or one of its competitors? The main competitors of Alpha Teknova include Nurix Therapeutics (NRIX), uniQure (QURE), Syndax Pharmaceuticals (SNDX), Trevi Therapeutics (TRVI), Jyong Biotech (MENS), Niagen Bioscience (NAGE), Xeris Biopharma (XERS), Nuvation Bio (NUVB), Maze Therapeutics (MAZE), and Cronos Group (CRON). These companies are all part of the "pharmaceutical products" industry. Alpha Teknova vs. Its Competitors Nurix Therapeutics uniQure Syndax Pharmaceuticals Trevi Therapeutics Jyong Biotech Niagen Bioscience Xeris Biopharma Nuvation Bio Maze Therapeutics Cronos Group Nurix Therapeutics (NASDAQ:NRIX) and Alpha Teknova (NASDAQ:TKNO) are both small-cap medical companies, but which is the better investment? We will contrast the two companies based on the strength of their analyst recommendations, media sentiment, earnings, institutional ownership, profitability, valuation, dividends and risk. Which has more volatility and risk, NRIX or TKNO? Nurix Therapeutics has a beta of 2.15, meaning that its share price is 115% more volatile than the S&P 500. Comparatively, Alpha Teknova has a beta of 0.33, meaning that its share price is 67% less volatile than the S&P 500. Is NRIX or TKNO more profitable? Alpha Teknova has a net margin of -60.90% compared to Nurix Therapeutics' net margin of -234.57%. Alpha Teknova's return on equity of -28.48% beat Nurix Therapeutics' return on equity.Company Net Margins Return on Equity Return on Assets Nurix Therapeutics-234.57% -45.26% -34.71% Alpha Teknova -60.90%-28.48%-19.73% Do insiders and institutionals believe in NRIX or TKNO? 13.8% of Alpha Teknova shares are held by institutional investors. 7.4% of Nurix Therapeutics shares are held by company insiders. Comparatively, 12.5% of Alpha Teknova shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term. Which has higher valuation and earnings, NRIX or TKNO? Alpha Teknova has lower revenue, but higher earnings than Nurix Therapeutics. Alpha Teknova is trading at a lower price-to-earnings ratio than Nurix Therapeutics, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNurix Therapeutics$88.38M9.96-$193.57M-$2.61-4.41Alpha Teknova$37.74M7.33-$26.75M-$0.48-10.79 Does the media favor NRIX or TKNO? In the previous week, Alpha Teknova had 1 more articles in the media than Nurix Therapeutics. MarketBeat recorded 5 mentions for Alpha Teknova and 4 mentions for Nurix Therapeutics. Nurix Therapeutics' average media sentiment score of 1.53 beat Alpha Teknova's score of 0.97 indicating that Nurix Therapeutics is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Nurix Therapeutics 2 Very Positive mention(s) 1 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Alpha Teknova 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive Do analysts rate NRIX or TKNO? Nurix Therapeutics currently has a consensus target price of $29.31, indicating a potential upside of 154.45%. Alpha Teknova has a consensus target price of $10.00, indicating a potential upside of 93.05%. Given Nurix Therapeutics' higher probable upside, equities research analysts plainly believe Nurix Therapeutics is more favorable than Alpha Teknova.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Nurix Therapeutics 0 Sell rating(s) 3 Hold rating(s) 14 Buy rating(s) 0 Strong Buy rating(s) 2.82Alpha Teknova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 SummaryAlpha Teknova beats Nurix Therapeutics on 10 of the 17 factors compared between the two stocks. Get Alpha Teknova News Delivered to You Automatically Sign up to receive the latest news and ratings for TKNO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding TKNO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TKNO vs. The Competition Export to ExcelMetricAlpha TeknovaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$276.29M$3.06B$5.69B$9.50BDividend YieldN/A2.37%4.58%4.01%P/E Ratio-10.7921.1828.1020.05Price / Sales7.33288.50432.4490.07Price / CashN/A42.7636.2258.56Price / Book3.348.378.665.87Net Income-$26.75M-$55.19M$3.25B$258.55M7 Day Performance21.31%5.88%4.23%3.74%1 Month Performance1.37%17.33%10.52%11.75%1 Year Performance26.96%4.42%34.41%18.03% Alpha Teknova Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TKNOAlpha Teknova2.2131 of 5 stars$5.18+0.2%$10.00+93.1%+45.9%$276.29M$37.74M-10.79240News CoverageAnalyst UpgradeNRIXNurix Therapeutics2.6575 of 5 stars$11.25+0.4%$29.31+160.6%-45.2%$857M$54.55M-4.31300QUREuniQure2.2039 of 5 stars$14.50-3.3%$37.82+160.8%+76.3%$821.09M$27.12M-3.30500Upcoming EarningsSNDXSyndax Pharmaceuticals3.5291 of 5 stars$9.73+2.9%$34.10+250.5%-60.9%$814.01M$23.68M-2.52110TRVITrevi Therapeutics3.8823 of 5 stars$6.82-0.6%$20.88+206.1%+148.3%$804.63MN/A-15.1620MENSJyong BiotechN/A$11.00+4.3%N/AN/A$802.09MN/A0.0031Quiet Period ExpirationNAGENiagen Bioscience1.447 of 5 stars$9.68-4.7%$13.22+36.6%N/A$800.70M$107.93M56.94120XERSXeris Biopharma4.006 of 5 stars$5.14+0.6%$6.25+21.6%+96.5%$799.12M$203.07M-17.13290News CoveragePositive NewsNUVBNuvation Bio2.2113 of 5 stars$2.36+2.4%$7.17+204.3%-32.3%$782.60M$7.87M-1.0060News CoverageAnalyst UpgradeGap UpMAZEMaze TherapeuticsN/A$16.66-6.3%$23.50+41.1%N/A$778.71M$167.50M0.00121News CoverageAnalyst ForecastLockup ExpirationAnalyst RevisionGap UpHigh Trading VolumeCRONCronos Group1.9825 of 5 stars$2.09+4.0%N/A-15.3%$775.22M$117.61M16.08450News Coverage Related Companies and Tools Related Companies NRIX Competitors QURE Competitors SNDX Competitors TRVI Competitors MENS Competitors NAGE Competitors XERS Competitors NUVB Competitors MAZE Competitors CRON Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:TKNO) was last updated on 7/26/2025 by MarketBeat.com Staff From Our PartnersMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump's 2025 Economic Revolution Is Here Are Your Retirement Savings Ready?Time is short. Trump's reforms may be coming fast—and the financial system roller coaster may be a ride that y...Create New Advertiser | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredHIDDEN IN THE BOOK OF GENESIS…“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | Sponsored[Shocking New Report] U.S. Dollar To Crash?The "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Teknova, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Teknova With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TKNO Stock Alerts